Total Non-Current Liabilities

$1.17B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$1.17Bperiod endingJun 30, 2026

LGND Quarterly Total Non-Current Liabilities ($2.20M → $1.17B)

Quarterly total non-current liabilities

High-resolution chart · PNG

LGND total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jun 30, 2001	144,873,000
Mar 31, 2001	141,601,000
Dec 31, 2000	140,132,000
Sep 30, 2000	122,896,000
Jun 30, 2000	121,421,000
Mar 31, 2000	119,809,000
Dec 31, 1999	139,500,000
Sep 30, 1999	157,500,000
Jun 30, 1999	132,800,000
Mar 31, 1999	131,100,000
Dec 31, 1998	140,500,000
Sep 30, 1998	99,700,000
Jun 30, 1998	48,900,000
Mar 31, 1998	52,200,000
Dec 31, 1997	51,400,000
Sep 30, 1997	49,600,000
Jun 30, 1997	51,600,000
Mar 31, 1997	50,800,000
Dec 31, 1996	53,800,000
Sep 30, 1996	48,000,000
Jun 30, 1996	51,400,000
Mar 31, 1996	50,600,000
Dec 31, 1995	49,800,000
Sep 30, 1995	49,600,000
Mar 31, 1995	12,000,000
Dec 31, 1994	12,300,000
Sep 30, 1994	12,300,000
Jun 30, 1994	2,400,000
Mar 31, 1994	2,200,000